bêta
IA Trial Radar

Les essais cliniques correspondant aux critères pour Diabète sont listés.

Je peux vous aider à comprendre votre état de santé, les traitements ou à trouver des essais cliniques près de chez vous.
Notre outil de recherche ne prend en charge que l'anglais. Pour la recherche et la discussion dans d'autres langues, utilisez l'IA Trial Radar ci-dessus ou sélectionnez les filtres de condition médicale et de lieu ci-dessous.
64 résultats trouvés
Affichage des 50 premiers
 
Pathologie
Diabète
×
 
Mots clés
Surveillance continue du glucose
×
 
Sexe
Tous
×
 
Phase
Phase I
×
 
Titre de l'étude
Statut
Accuracy, Reliability and Safety of GlucoMen®Day, a New Generation Microdialysis Continuous Glucose Monitor NCT01407315
Terminé
Correlation of Continuous Glucose Monitoring and Glucose Tolerance Testing With Pregnancy Outcomes NCT00850135
TerminéRésultats publiés
A Comparison Study of Prototype Continuous Glucose Sensors in the Intradermal and Subcutaneous Spaces NCT01093833
Terminé
Care Partner-Assisted Diabetes Self-Management Through Linking Continuous Glucose Monitoring With Mobile Health: Improving Outcomes for Older Adults With Mild Cognitive Impairment (CP-CGMH) NCT05601583
Actif, ne recrute pas
Continuous Ketone Monitoring in People With Type 1 Diabetes Using SGLT2 Inhibitors (EmpaCKM) NCT06753994
En recrutement
Glucose Clamp Study to Prove Hypo- and Hyperglycemic Episodes Using a Non-invasive Glucose Monitoring Device NCT01060917
Terminé
Changes in Serum Electrolytes at Different Glucose Concentrations + Impact on a Non-invasive Glucose Monitoring Method NCT01058577
Terminé
Evaluation of Continuous Glucose Monitoring in Participants With Type 2 Diabetes Mellitus (MK-0000-258 AM2) NCT01537120
TerminéRésultats publiés
Changing Physical Activity Behavior in Individuals With Type 2 Diabetes Using Counceling and Information From Continuous Glucose Monitoring NCT00542698
Terminé
Sleep Effectiveness and Insulin and Glucose Homeostasis NCT01887691
Interrompu
Repeated Dose Study With a New Insulin Glargine Formulation and Lantus® on 24-hour Glucose Profile in Japanese Patients With Type 1 Diabetes Mellitus NCT01676233
Terminé
MDRS for Prevention of Nocturnal Hypoglycemia NCT01509157
Terminé
Pharmacodynamics of Mitiglinide/Sitagliptin Compared to Mitiglinide and Sitagliptin NCT01422590
Terminé
Effect of a Fixed Pramlintide: Insulin Dose Ratio on Postprandial Glucose in Type 1 Diabetes Mellitus NCT02500979
TerminéRésultats publiés
Tandem Predictive Low Glucose Suspend Inpatient Feasibility Study NCT02877771
Terminé
A Randomised Trial Evaluating Continuous Subcutaneous Infusion of Formulations of NN1218 and NovoLog® in Subjects With Type 1 Diabetes NCT01682902
Terminé
A Study to Assess the Effects of CT-868 Treatment on Glucose Homeostasis in Participants with Type 1 Diabetes NCT05794581
Terminé
Effectiveness Study of Pramlintide to Treat Post-Transplant Diabetes Mellitus NCT01165944
Retiré
A Study to Evaluate the Effect of AZD6793 on the Pharmacokinetics and Pharmacodynamics of Metformin in Participants With Type 2 Diabetes Mellitus (IRAK4) NCT07433062
En recrutement
Inpatient Evaluation of the MD-Logic Artificial Pancreas System in Patients With Type 1 Diabetes (MD-Logic- Cont) NCT01501032
Retiré
Feasibility Study Assessing the Ability of an Insulin Pump-controlling Algorithm to Minimize Hypoglycemia NCT01919385
Terminé
A Trial Investigating the Continuous Subcutaneous Insulin Infusion of a Liquid Formulation of BioChaperone Insulin Lispro in Comparison to Humalog® NCT02562313
Terminé
Chinese Multiple Dose Escalation (MDE) High Dose Study (COTA China PK) NCT05437848
Terminé
Investigate Effect of AMG 151 on 24-hour Ambulatory Blood Pressure & Glucose Levels in Type 2 Diabetes Mellitus Subjects NCT01755442
Interrompu
Inpatient Evaluation of an Automated Closed-Loop Control-to-Range System (CTR) NCT01271023
Terminé
CGM-Guided Acarbose for Painful Diabetic Neuropathy NCT07436585
Terminé
Relationship Between Gastric Emptying and Glycemic Variability in Type 1 Diabetes Mellitus NCT02755064
Terminé
Single Dose Study of PF-04991532 in Healthy Subjects NCT01102673
Terminé
A Study of LY2608204 in Patients With Type 2 Diabetes NCT01247363
TerminéRésultats publiés
Low Dose Empagliflozin in Adults With Type 1 Diabetes on Closed Loop Insulin System (CL-LoDE) NCT04450563
Terminé
To Investigate the Efficacy and Safety of Individualized Doses of BioChaperone Insulin Lispro in Comparison to Humalog® U-100 in Patients With Type 1 Diabetes Mellitus NCT02528396
Terminé
Improving Post-Prandial Blood Glucose Control With Afrezza During Closed-Loop Therapy NCT03234491
Terminé
Safety and Tolerability Study of Cotadutide in Japanese Obese Subjects With Type 2 Diabetes Melitus NCT04208620
Terminé
A Study of an Automated Insulin Delivery System in Participants With Type 1 Diabetes Mellitus (T1DM) NCT03367390
Terminé
Phase 1/2a, Randomized, Double-Blind, Placebo-Controlled, Study to Assess Safety, Tolerability, PK and PD Response of PB1023 Injection Following Single and Multiple SQ Doses in Adults With Type 2 Diabetes Mellitus NCT01236404
Terminé
Combination Adjunctive Therapy to Address Multiple Metabolic Imbalances in Type 1 Diabetes (SOTA) NCT05696366
En recrutement
First in Man Study With SLV341 NCT00887445
Interrompu
Roflumilast Plus Alogliptin Proof-of-Mechanism Study in Type2 Diabetes NCT01664624
TerminéRésultats publiés
A First-time-in-human Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Ascending Doses of GSK189075A in Healthy Subjects and in Subjects With Type 2 Diabetes Mellitus NCT01571661
Terminé
Effect of Oral 6-bromotryptophan on Safety, Pharmacokinetics and Efficacy in Metabolic Syndrome Individuals (BROMO) NCT05971524
Inconnu
Phase 1 Multicenter, Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Response of PE0139 Injection in Adult Subjects With Type 2 Diabetes Mellitus NCT01835730
Terminé
Effect of Prebiotics on the Gut Microbiome Profile and Beta Cell Function NCT04114357
TerminéRésultats publiés
A Study of the Effect of LY2189265 on Two Blood Pressure Drugs NCT01324388
TerminéRésultats publiés
Open-label Investigation of the Safety and Effectiveness of DIABECELL(R) in Patients With Type I Diabetes Mellitus NCT00940173
Terminé
Phase 1 Trial of Arginine Hydrochloride for the Management of Diabetic Ketoacidosis in Type 2 Diabetes NCT07167693
En recrutement
Effect of Alpelisib in Healthy Volunteers NCT05733455
Terminé
A Study to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of a Single Dose of SAR438544 in Comparison to Glucagon in Type 1 Diabetes Mellitus Patients Under Induced Hypoglycemia NCT02635243
Retiré
Single Dose Escalation Study of PF-05190457 in Healthy Volunteers NCT01247896
Terminé
Time Restricted Eating in Patients With Microalbuminuria (TREK) NCT06884059
Pas encore en recrutement
A First-in-human Clinical Trial Using a Gene Therapy With Patient's Own Stem Cells to Treat Early Type 1 Diabetes (IMMUNOSTEM) NCT06938334
Pas encore en recrutement